Analysis Novo Nordisk’s Real-World Retort and a Muscle-Preserving Alliance: The ADA Story
Novo Nordisk arrived at the American Diabetes Association’s annual meeting in New Orleans armed with a flood of fresh clinical evidence, yet the company’s shares remain stuck in a deep...